An ERG channel inhibitor from the scorpion Buthus eupeus

被引:84
作者
Korolkova, YV
Kozlov, SA
Lipkin, AV
Pluzhnikov, KA
Hadley, JK
Filippov, AK
Brown, DA
Angelo, K
Strobaek, D
Jespersen, T
Olesen, SP
Jensen, BS
Grishin, EV
机构
[1] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
[2] UCL, Dept Pharmacol, London WC1E 6BT, England
[3] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark
[4] NeuroSearch AS, DK-2750 Ballerup, Denmark
关键词
D O I
10.1074/jbc.M005973200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The isolation of the peptide inhibitor of M-type K+ current, BeKm-1, from the venom of the Central Asian scorpion Buthus eupeus has been described previously (Fillipov A. K,, Kozlov, S, A, Pluzhnikov, K. A., Grishin, E. V., and Brown, D, A (1996) FEBS Lett, 384, 277-280). Here we report the cloning, expression, and selectivity of BeKm-1. A full-length cDNA of 365 nucleotides encoding the precursor of BeKm-1 was isolated using the rapid amplification of cDNA ends polymerase chain reaction technique from mRNA obtained from scorpion telsons, Sequence analysis of the cDNA revealed that the precursor contains a signal peptide of 21 amino acid residues. The mature toxin consists of 36 amino acid residues. BeKm-1 belongs to the family of scorpion venom potassium channel blockers and represents a new subgroup of these toxins. The recombinant BeKm-1 was produced as a Protein A fusion product in the periplasm of Escherichia coli. After cleavage and high performance liquid chromatography purification, recombinant BeKm-1 displayed the same properties as the native toxin, Three BeKm-1 mutants (R27K, F32K, and R27K/F32K) were generated, purified, and characterized. Recombinant wild-type BeKm-1 and the three mutants partly inhibited the native M-like current in NG108-15 at 100 nM. The effect of the recombinant BeKm-1 on different K+ channels was also studied. BeKm-1 inhibited hERG1 channels with an IC50 of 3.3 nM, but had no effect at 100 nM on hEAG, hSK1, rSK2, hIK, hBK, KCNQ1/KCNE1, KCNQ2/KCNQ3, KCNQ4 channels, and minimal effect on rELK1. Thus, BeKm-1 was shown to be a novel specific blocker of hERG1 potassium channels.
引用
收藏
页码:9868 / 9876
页数:9
相关论文
共 57 条
[1]   MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia [J].
Abbott, GW ;
Sesti, F ;
Splawski, I ;
Buck, ME ;
Lehmann, WH ;
Timothy, KW ;
Keating, MT ;
Goldstein, SAN .
CELL, 1999, 97 (02) :175-187
[2]   PHARMACOLOGICAL INHIBITION OF THE M-CURRENT [J].
ADAMS, PR ;
BROWN, DA ;
CONSTANTI, A .
JOURNAL OF PHYSIOLOGY-LONDON, 1982, 332 (NOV) :223-262
[3]   The signature sequence of voltage-gated potassium channels projects into the external vestibule [J].
Aiyar, J ;
Rizzi, JP ;
Gutman, GA ;
Chandy, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (49) :31013-31016
[5]   3-DIMENSIONAL STRUCTURE OF NATURAL CHARYBDOTOXIN IN AQUEOUS-SOLUTION BY H-1-NMR - CHARYBDOTOXIN POSSESSES A STRUCTURAL MOTIF FOUND IN OTHER SCORPION TOXINS [J].
BONTEMS, F ;
ROUMESTAND, C ;
BOYOT, P ;
GILQUIN, B ;
DOLJANSKY, Y ;
MENEZ, A ;
TOMA, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 196 (01) :19-28
[6]   A recombinant insect-specific alpha-toxin of Buthus occitanus tunetanus scorpion confers protection against homologous mammal toxins [J].
BouhaoualaZahar, B ;
Ducancel, F ;
Zenouaki, I ;
BenKhalifa, R ;
Borchani, L ;
Pelhate, M ;
Boulain, JC ;
ElAyeb, M ;
Menez, A ;
Karoui, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 238 (03) :653-660
[7]   A COMPLEMENTATION ANALYSIS OF RESTRICTION AND MODIFICATION OF DNA IN ESCHERICHIA COLI [J].
BOYER, HW ;
ROULLAND.D .
JOURNAL OF MOLECULAR BIOLOGY, 1969, 41 (03) :459-&
[8]   MEMBRANE CURRENT RESPONSES OF NG108-15 MOUSE NEUROBLASTOMAXRAT GLIOMA HYBRID-CELLS TO BRADYKININ [J].
BROWN, DA ;
HIGASHIDA, H .
JOURNAL OF PHYSIOLOGY-LONDON, 1988, 397 :167-184
[9]   MUSCARINIC SUPPRESSION OF A NOVEL VOLTAGE-SENSITIVE K+ CURRENT IN A VERTEBRATE NEURON [J].
BROWN, DA ;
ADAMS, PR .
NATURE, 1980, 283 (5748) :673-676
[10]   Molecular and functional diversity of K+ channels [J].
Christie, MJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (12) :944-951